It was an EGD with ultrasound that focused on the esophagus and nearby areas to help with diagnosis and staging
A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result
When Wegovy gained Food and Drug Administration approval for weight loss in 2021 as a weekly injectable, prescriptions soared, reaching nearly 121,000 scripts in 2023, the study said
Obesity is a major risk factor for cardiovascular disease, the leading cause of death in people with common arthritides such as osteoarthritis (OA), gout, rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
MRFs annually
If you experience persistent diarrhea or other concerning symptoms, consider adjusting the dosage or discontinuing use